menu

Medical Program: Clinical Implications of Heart Failure Trials Presented at the ACC.20/WCC Virtual Late-Breaker Session

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Clinical Implications of Heart Failure Trials Presented at the ACC.20/WCC Virtual Late-Breaker Session

close
Clinical Implications of Heart Failure Trials Presented at the ACC.20/WCC Virtual Late-Breaker Session
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    Tune in as Drs. Javed Butler (University of Mississippi) and John McMurray (University of Glasgow) discuss highlights of the heart failure clinical trials VICTORIA, DAPA-HF, PIONEER-HF, and PARADIGM-HF, which were presented at the ACC.20/WCC Virtual late-breaker session. These trials increase available medical options and the complexity of heart failure management, so join our leading experts for guidance on incorporating these data into your clinical practice.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    Tune in as Drs. Javed Butler (University of Mississippi) and John McMurray (University of Glasgow) discuss highlights of the heart failure clinical trials VICTORIA, DAPA-HF, PIONEER-HF, and PARADIGM-HF, which were presented at the ACC.20/WCC Virtual late-breaker session. These trials increase available medical options and the complexity of heart failure management, so join our leading experts for guidance on incorporating these data into your clinical practice.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 12/2/20